JX: Data curation, Funding acquisition, Writing review & editing
We just want you to use them with the same seriousness you would use for any other health decision
Blog Obesity care and GLP-1s September 5 1 min read From Weight Loss to Risk: Understanding GLP-1s Impact on Eating Disorders Weight loss medication abuse is not new
Tesamorelin targets HIV-related lipodystrophy with 20% visceral fat reduction over 6 months, while sermorelin treats broader growth hormone deficiency with moderate fat loss effects Tesamorelin requires daily 2mg injections at $1,500-2,500 monthly, while sermorelin uses flexible dosing (0 } Sermorelin's Physiology Natural Stimulation: Endogenous GHRH receptor activation Preservation of natural GH pulsatility Maintenance of feedback mechanisms Support of circadian rhythms Gradual system optimization Normalized GH secretion patterns Balanced IGF-1 production Enhanced somatostatin regulation Improved hormone synchronization Sustained therapeutic response Clinical Research Findings Several studies have documented the efficacy and safety profiles of both peptides
The FDA Wegovy label lists hair loss as an adverse reaction in 3% of adults and 4% of adolescents with obesity in clinical trials
In preclinical studies, it has shown remarkable effects on memory and learning in animal models